By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sorrento Therapeutics, Inc. 

6042 Cornerstone Court W,

San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a



Company News
Sorrento (SRNE) Announced FDA Authorization Of IND To Commence Clinical Trial Of RTX In Intractable Cancer Pain 6/29/2017 9:45:53 AM
Sorrento (SRNE) Announces Dismissal Of Lawsuits 6/15/2017 7:45:45 AM
Sorrento (SRNE)' Pain Subsidiary, Scilex, Announces Positive Data From Head To Head Adhesion Study With Its Lead Product, ZTlido 6/14/2017 7:31:24 AM
Human Longevity Co-Founder To Helm Newly Launched Sorrento (SRNE) Spinoff Celularity 6/13/2017 7:16:22 AM
Sorrento (SRNE) Announces The Completion Of GMP Manufacturing Plant In Suzhou, China To Support Its Growing Antibody-Drug Conjugate (ADC) Pipeline And Service Business 5/4/2017 8:10:40 AM
Sorrento (SRNE) Announces Closing Of Its Acquisition Of Virttu Biologics 4/28/2017 8:47:34 AM
Sorrento (SRNE) Announces Closing Of Public Offering Of Common Stock 4/20/2017 7:32:53 AM
Sorrento (SRNE) Announces Pricing of Public Offering Of Common Stock 4/13/2017 11:19:46 AM
Sorrento (SRNE) Announces Proposed Public Offering Of Common Stock 4/13/2017 11:05:24 AM
Sorrento (SRNE) Anti-CEA CAR-T Demonstrates Promising Clinical Activity And Safety In Phase Ib Clinical Trial 4/4/2017 6:37:57 AM